184 related articles for article (PubMed ID: 37561721)
21. Development of a panel of three multiplex allele-specific qRT-PCR assays for quick differentiation of recombinant variants and Omicron subvariants of SARS-CoV-2.
Li J; Gao Z; Chen J; Cheng R; Niu J; Zhang J; Yang Y; Yuan X; Xia J; Mao G; Liu H; Dong Y; Wu C
Front Cell Infect Microbiol; 2022; 12():953027. PubMed ID: 36061868
[TBL] [Abstract][Full Text] [Related]
22. Accelerating pandemic response with the emergency Omicron RT-PCR test: A comprehensive solution for COVID-19 diagnosis and tracking.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Chen CS; Tang SH; Perng CL; Chang FY; Wang CH; Hung YJ; Shang HS
J Med Virol; 2023 Jul; 95(7):e28914. PubMed ID: 37394776
[TBL] [Abstract][Full Text] [Related]
23. Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract.
Hu B; Chan JF; Liu Y; Liu H; Chen YX; Shuai H; Hu YF; Hartnoll M; Chen L; Xia Y; Hu JC; Yuen TT; Yoon C; Hou Y; Huang X; Chai Y; Zhu T; Shi J; Wang Y; He Y; Cai JP; Zhou J; Yuan S; Zhang J; Huang JD; Yuen KY; To KK; Zhang BZ; Chu H
EBioMedicine; 2024 Jan; 99():104916. PubMed ID: 38101297
[TBL] [Abstract][Full Text] [Related]
24. Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge : A Cross-Sectional Study.
Schrom J; Marquez C; Pilarowski G; Wang CY; Mitchell A; Puccinelli R; Black D; Rojas S; Ribeiro S; Tulier-Laiwa V; Martinez J; Payan J; Rojas S; Jones D; Martinez D; Nakamura R; Chamie G; Jain V; Petersen M; DeRisi J; Havlir D
Ann Intern Med; 2022 May; 175(5):682-690. PubMed ID: 35286144
[TBL] [Abstract][Full Text] [Related]
25. [Rapid detection and genotyping of SARS-CoV-2 Omicron BA.4/5 variants using a RT-PCR and CRISPR-Cas12a-based assay].
Ma Y; Zou L; Liang Y; Liu Q; Sun Q; Pang Y; Lin H; Deng X; Tang S
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):516-526. PubMed ID: 37202186
[TBL] [Abstract][Full Text] [Related]
26. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2.
Qu P; Evans JP; Faraone JN; Zheng YM; Carlin C; Anghelina M; Stevens P; Fernandez S; Jones D; Lozanski G; Panchal A; Saif LJ; Oltz EM; Xu K; Gumina RJ; Liu SL
Cell Host Microbe; 2023 Jan; 31(1):9-17.e3. PubMed ID: 36476380
[TBL] [Abstract][Full Text] [Related]
27. Classification of Omicron BA.1, BA.1.1, and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data.
Hirotsu Y; Maejima M; Shibusawa M; Natori Y; Nagakubo Y; Hosaka K; Sueki H; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
Int J Infect Dis; 2022 Sep; 122():486-491. PubMed ID: 35760380
[TBL] [Abstract][Full Text] [Related]
28. Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants.
Selvavinayagam ST; Yong YK; Joseph N; Hemashree K; Tan HY; Zhang Y; Rajeshkumar M; Kumaresan A; Kalpana R; Kalaivani V; Monika AVD; Suvaithenamudhan S; Kannan M; Murugesan A; Narayanasamy K; Palani S; Larsson M; Shankar EM; Raju S
Front Public Health; 2022; 10():1018399. PubMed ID: 36211690
[TBL] [Abstract][Full Text] [Related]
29. Clinical severity of Omicron subvariants BA.1, BA.2, and BA.5 in a population-based cohort study in British Columbia, Canada.
Russell SL; Klaver BRA; Harrigan SP; Kamelian K; Tyson J; Hoang L; Taylor M; Sander B; Mishra S; Prystajecky N; Janjua NZ; Zlosnik JEA; Sbihi H
J Med Virol; 2023 Jan; 95(1):e28423. PubMed ID: 36546412
[TBL] [Abstract][Full Text] [Related]
30. Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern.
Yan T; Xu Y; Zheng R; Zeng X; Chen Z; Lin S; Xia Z; Liao Y; Zhang Y; Li Q
Microbiol Spectr; 2022 Oct; 10(5):e0322222. PubMed ID: 36106882
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of clinical and immunological profiles across Omicron BA.5.2 subvariants using next-generation sequencing in a Chinese cohort.
Huang J; Xia M; Liu R; Wang S; Duan X; Peng J; Li E; Zhou Y; Li C; Zhang Q; Tian J; Wang X; Su Z; Tan J; Peng B; Zhang J; Li J; Dai L; Lei M
Front Cell Infect Microbiol; 2023; 13():1288914. PubMed ID: 37965255
[TBL] [Abstract][Full Text] [Related]
32. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
[TBL] [Abstract][Full Text] [Related]
33. The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends.
Farahat RA; Abdelaal A; Umar TP; El-Sakka AA; Benmelouka AY; Albakri K; Ali I; Al-Ahdal T; Abdelazeem B; Sah R; Rodriguez-Morales AJ
Infez Med; 2022; 30(4):480-494. PubMed ID: 36482957
[TBL] [Abstract][Full Text] [Related]
34. Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant.
Bekliz M; Adea K; Puhach O; Perez-Rodriguez F; Marques Melancia S; Baggio S; Corvaglia AR; Jacquerioz F; Alvarez C; Essaidi-Laziosi M; Escadafal C; Kaiser L; Eckerle I
Microbiol Spectr; 2022 Aug; 10(4):e0085322. PubMed ID: 35938792
[TBL] [Abstract][Full Text] [Related]
35. Epidemiological Insights into the Omicron Outbreak via MeltArray-Assisted Real-Time Tracking of SARS-CoV-2 Variants.
Yan T; Zheng R; Li Y; Sun S; Zeng X; Yue Z; Liao Y; Hu Q; Xu Y; Li Q
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140638
[TBL] [Abstract][Full Text] [Related]
36. Mapping the Early Dispersal Patterns of SARS-CoV-2 Omicron BA.4 and BA.5 Subvariants in the Absence of Travel Restrictions and Testing at the Borders in Europe.
Kostaki EG; Mossialos E; Tseti I; Sfikakis PP; Paraskevis D
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680171
[TBL] [Abstract][Full Text] [Related]
37. Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.
Wilhelm A; Widera M; Grikscheit K; Toptan T; Schenk B; Pallas C; Metzler M; Kohmer N; Hoehl S; Marschalek R; Herrmann E; Helfritz FA; Wolf T; Goetsch U; Ciesek S
EBioMedicine; 2022 Aug; 82():104158. PubMed ID: 35834885
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Nasopharyngeal and Saliva Swab Nucleic Acid Amplification and Rapid Antigen Testing To Detect Omicron SARS-CoV-2 Variant of Concern: a Prospective Clinical Trial (OMICRON).
Kritikos A; Caruana G; Lazor-Blanchet C; Currat M; Chiche JD; Vollenweider P; Bart PA; Opota O; Greub G
Microbiol Spectr; 2022 Dec; 10(6):e0392322. PubMed ID: 36346225
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Panbio COVID-19 Antigen Rapid Diagnostic Test in Subjects Infected with Omicron Using Different Specimens.
Galliez RM; Bomfim L; Mariani D; Leitão IC; Castiñeiras ACP; Gonçalves CCA; Ortiz da Silva B; Cardoso PH; Arruda MB; Alvarez P; Brindeiro R; Ota VA; Rodrigues DGM; da Costa LJ; Ferreira ODC; Castiñeiras TMPP; Faffe DS; Tanuri A
Microbiol Spectr; 2022 Jun; 10(3):e0125022. PubMed ID: 35652635
[TBL] [Abstract][Full Text] [Related]
40. Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Subvariant BA.2 in a Single-Source Community Outbreak.
Cheng VCC; Ip JD; Chu AWH; Tam AR; Chan WM; Abdullah SMU; Chan BPC; Wong SC; Kwan MYW; Chua GT; Ip P; Chan JMC; Lam BHS; To WK; Chuang VWM; Yuen KY; Hung IFN; To KKW
Clin Infect Dis; 2022 Aug; 75(1):e44-e49. PubMed ID: 35271728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
